Making end points meet.
Koretz
R L
RL
D015415:Biomarkers / Q000097:blood*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000401:mortality / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D017093:Liver Failure / Q000453:epidemiology; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D015996:Survival Rate; D000637:Transaminases / Q000097:blood; D016896:Treatment Outcome; D019562:Viral Load
D015415:Biomarkers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D012254:Ribavirin; D000637:Transaminases